Abiopharma

News list

Malzahn Craig 🔴 sold 234 shares of REGENXBIO Inc. (RGNX) at $8.93 Transaction Date: Sep 01, 2025 | Filing ID: 006079

Full text

News bot Sept. 3, 2025, 8:50 p.m.
🔍 Malzahn Craig (Executive)

Company: REGENXBIO Inc. (RGNX)

Report Date: 2025-09-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 234
Detailed Transactions and Holdings:
- Sold 234 shares of Common Stock at $8.93 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: false | shares_owned_after: 17,585.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 1, 2022. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 29, 2025.